The Ups and Downs of Blood Sugar Management
Have you read the latest headlines? The rate of people with metabolic syndrome — the precursor to diabetes — continues to grow. And the prevalence is increasing in young adults as well. That means the threat of diabetes expands with it. Along for
the ride is insulin resistance, a condition where the body’s produc- tion of insulin can’t keep up with the demand, so blood sugar levels increase. It’s also a stepping stone to diabetes. This is a dangerous trend that must be reversed. Thankfully, Relìv has made inroads.
Two years ago, Relìv introduced GlucAffect®, a revolutionary, targeted nutritional supplement created to address the cascade of heath problems caused by metabolic syndrome. The product brings together an unprecedented array of clinically proven ingre- dients to lower blood sugar and tackle cardiovascular issues.
In an eight-week clinical trial of GlucAffect, participants decreased their fasting blood glucose by 30.4 percent, which returned participants to healthy blood sugar values; their HbA1c (which shows an average of blood sugar levels over time) decreased from 7.59 percent to 6.33 percent, which put them in normal range; and they lost an average of 15 pounds.
Results like these are being duplicated by people around the world. With the rising rates of metabolic syndrome, it’s vital we share GlucAffect and all Relìv products so more people can enjoy good health — and a brighter future.
To Your Health,
Dr. Carl W. Hastings Relìv Vice Chairman and Chief Scientific Officer
No comments:
Post a Comment